peptide elongation factor 2 has been researched along with epidermal growth factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyoshi, DE; Arrigo, DA; Bacha, P; Genbauffe, FS; Nichols, JC; Rhoad, AE; Shaw, JP; Sullivan, B; Thomas, J | 1 |
FitzGerald, DJ; Pastan, I; Willingham, MC | 1 |
1 review(s) available for peptide elongation factor 2 and epidermal growth factor
Article | Year |
---|---|
Pseudomonas exotoxin--immunotoxins.
Topics: ADP Ribose Transferases; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Bacterial Toxins; Cross-Linking Reagents; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Exotoxins; Female; Genes, Bacterial; Humans; Immunotoxins; Mice; Mice, Nude; Ovarian Neoplasms; Peptide Elongation Factor 2; Peptide Elongation Factors; Protein Engineering; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Ricin; Transferrin; Virulence Factors | 1988 |
1 other study(ies) available for peptide elongation factor 2 and epidermal growth factor
Article | Year |
---|---|
Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins.
Topics: Adenosine Diphosphate Ribose; Cell Death; Diphtheria Toxin; Epidermal Growth Factor; ErbB Receptors; Escherichia coli; Genetic Engineering; Humans; In Vitro Techniques; Peptide Elongation Factor 2; Peptide Elongation Factors; Plasmids; Recombinant Fusion Proteins | 1991 |